Literature DB >> 7042716

Poly(ADP-ribosyl)ation of chromosomal proteins in the HeLa S3 cell cycle.

S Tanuma, Y Kanai.   

Abstract

Change in the level of poly(ADP-ribosyl)ation during the cell cycle of HeLa S3 cells was examined in three different in vitro systems: isolated nuclei, chromatin, and poly(ADP-ribose) polymerase extracted from isolated nuclei, and by the direct immunofluorescent antibody technique in situ. In isolated nuclei, after release from thymidine-hydroxyurea double block, the level of poly(ADP-ribosyl)ation was low in the S phase and increased in the late G2 phase with a peak in the M phase. In chromatin, the level began to increase in the mid-late S phase, was maintained at a high level throughout the G2 phase, decreased in the M phase, and became basal during the G1 phase. The activity of poly(ADP-ribose) polymerase extracted from isolated nuclei was relatively high throughout the cell cycle and was highest in the G2 phase. Similar changes during the HeLa S3 cell cycle were observed in the three systems after release from Colcemid block. In synchronously growing HeLa S3 cells in situ, nuclei in the G2-M phase were stained strongest for poly(ADP-ribose) by the immunofluorescent staining. These results were consistent with the peak of poly(ADP-ribosyl)ation in the G2-M phase observed in the nuclear system in vitro.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7042716

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  ARTD1 regulates cyclin E expression and consequently cell-cycle re-entry and G1/S progression in T24 bladder carcinoma cells.

Authors:  Karolin Léger; Ann-Katrin Hopp; Monika Fey; Michael O Hottiger
Journal:  Cell Cycle       Date:  2016-06-13       Impact factor: 4.534

2.  Inhibition of Aurora-B kinase activity by poly(ADP-ribosyl)ation in response to DNA damage.

Authors:  Lucia Monaco; Ullas Kolthur-Seetharam; Romain Loury; Josiane Ménissier-de Murcia; Gilbert de Murcia; Paolo Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-22       Impact factor: 11.205

Review 3.  Molecular and biochemical features of poly (ADP-ribose) metabolism.

Authors:  D Lautier; J Lagueux; J Thibodeau; L Ménard; G G Poirier
Journal:  Mol Cell Biochem       Date:  1993-05-26       Impact factor: 3.396

4.  Bimodal induction of sister-chromatid exchanges by luminol, an inhibitor of poly(ADP-ribose) synthetase, during the S-phase of the cell cycle.

Authors:  T Ikushima
Journal:  Chromosoma       Date:  1990-09       Impact factor: 4.316

5.  Modulation of poly(ADP-ribose) polymerase during neutrophilic and monocytic differentiation of promyelocytic (NB4) and myelocytic (HL-60) leukaemia cells.

Authors:  M Bhatia; J B Kirkland; K A Meckling-Gill
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

6.  DNA strand breaks alter histone ADP-ribosylation.

Authors:  T Boulikas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  Cell cycle-dependent intervention by benzamide of carcinogen-induced neoplastic transformation and in vitro poly(ADP-ribosyl)ation of nuclear proteins in human fibroblasts.

Authors:  E Kun; E Kirsten; G E Milo; P Kurian; H L Kumari
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

8.  CHFR protein regulates mitotic checkpoint by targeting PARP-1 protein for ubiquitination and degradation.

Authors:  Lisa Kashima; Masashi Idogawa; Hiroaki Mita; Miki Shitashige; Tesshi Yamada; Kazuhiro Ogi; Hiromu Suzuki; Minoru Toyota; Hiroyoshi Ariga; Yasushi Sasaki; Takashi Tokino
Journal:  J Biol Chem       Date:  2012-02-15       Impact factor: 5.157

9.  NAD-dependent inhibition of the NAD-glycohydrolase activity in A549 cells.

Authors:  Enrico Balducci; Luigi G Micossi
Journal:  Mol Cell Biochem       Date:  2002-04       Impact factor: 3.396

10.  PARP1 gene expression is downregulated by knockdown of PARG gene.

Authors:  Fumiaki Uchiumi; Takeshi Watanabe; Ryo Ohta; Hideaki Abe; Sei-Ichi Tanuma
Journal:  Oncol Rep       Date:  2013-03-04       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.